Aeluma, Inc. (ALMU)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-29
$8.04+2.16%
Close 2026-10-29 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-29
Research Workspace
Put ALMU beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Semiconductors is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Operating losses improve from -$3.35M in Q3 2026: Comparison needs review.
View ThesisRevenue is contracting — down about 4% over the past year.
View GrowthManagement screens weak on capital allocation, margins, market reaction to earnings.
View ManagementThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 79% in its worst 12-month stretch.
View RiskALMU’s bet is scaling wafer production through manufacturing partnerships and CHIPS-backed development. Revenue growth is unavailable, and the latest recorded quarter shows a non-GAAP loss. There is no valuation bridge or priced-in reading to anchor a multiple comparison. Recent results sit below the industry group, and the operating-loss comparison needs review. Our model puts the next-quarter miss probability near 42%. Our read is provisional, and the thesis is on watch.
Trailing returns as of 2026-10-29. ALMU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 2 analysts currently covering ALMU (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare ALMU with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ALMU Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Semiconductors — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put ALMU next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Leverage CHIPS Act funding to accelerate R&D and commercialization
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Secures funding to accelerate R&D and commercialization efforts.
Advances: Expand manufacturing readiness and partnerships
Partnership enhances manufacturing readiness and supports growth objectives.
Financial results confirm revenue guidance.
Advances: Narrow revenue guidance to $4.2M-$4.6M for FY 2026
Revenue guidance aligns with management's objectives.